Release Date: 31/07/19 12:28 Summary: Appendix 4C - quarterly Price Sensitive: Yes Download Document 435.61KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%